SEC Form 4 · accession 0001125345-19-000016
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Spitznagel
Officer — Sr VP, BPD & Manufacturing
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2019 | M | 1,770 | $7.51 | A | 1,770 | D | |
| Common Stock | Feb 6, 2019 | S | 1,770 | $30.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $7.51 | Feb 6, 2019 | M | 1,770 | D | Mar 18, 2014 | Sep 17, 2023 | Common Stock | 1,770 | 62,147 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018.